What is the Astal Laboratories Ltd share price today?

The share price of BSE:ASTALLTD-X on 01 Oct 2026 (as of 15:05:30 IST) is ₹70.48.

What is the BSE:ASTALLTD-X 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:ASTALLTD-X 52 week high low range shows a high of ₹103.2 and a low of ₹60.45.

What is the Astal Laboratories Ltd market cap?

As on 01 Oct 2026, Astal Laboratories Ltd market cap is ₹3105780000.

What is the shareholding pattern of Astal Laboratories Ltd Stock?

The shareholding pattern of Astal Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 4.53% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 95.47% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Astal Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Astal Laboratories Ltd is 31.9033, and the Price-to-Book (PB) ratio is 2.3169, as on 01 Oct 2026.

Astal Laboratories Share Price

54.27+3.02 (+5.89%)

-44.40% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+5.89%

1 Week

-12.04%

1 Month

-23.85%

3 Month

-33.12%

6 Month

-38.91%

YTD

-37.51%

1 Year

-44.40%

5 Year

10 Year

Max

+20.44%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

51.00

49.99

High

58.45

62.90

71.40

89.50

91.90

99.90

About

Macro International Ltd is engaged in the exporting of goods as well as sales through the departmental stores. The company trades in bridles, halters, rugs, saddles, strip leather, reins, shoes Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

ASTALLTD-XNSE

LTP

1W Low

1W High

Market cap (₹)

1788.9+10.65 (0.60%)

1720.80

1796.45

4,25,150Cr

9981.5+266.5 (2.74%)

9866.35

10080.20

2,66,265Cr

4640+4.85 (0.10%)

4555

4665.10

1,76,301Cr

2319.4-72.6 (-3.04%)

2252.50

2442

1,25,352Cr

1260+16 (1.29%)

1217.70

1264.20

1,23,591Cr

1374.5+24.3 (1.80%)

1337.30

1390.70

1,14,351Cr

1395.9+15.9 (1.15%)

1364.75

1400.60

1,12,474Cr

2486-2.75 (-0.11%)

2457.35

2523.70

1,02,315Cr

1701.6+23.8 (1.42%)

1656.90

1707.60

97,757Cr

2020.5+11.5 (0.57%)

1989.10

2061.55

92,007Cr

54.55-7.15 (-11.59%)

49.99

62.90

224Cr

Astal Laboratories Share Price

54.27+3.02 (+5.89%)

-44.40% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year289%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year65%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-47%

Return on Equity

10 years18%

5 years18%

3 years18%

Last year8%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	289%
-	-	-	65%
-	-	-	-47%
18%	18%	18%	8%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

ASTALLTD-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,788.9	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
9,981.5	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,640	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,319.4	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,260	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,374.5	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,395.9	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,486	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,701.6	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,020.5	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
54.55	₹224 Cr	15.26	2.15	3.64	₹15 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Mar 2025
₹101 Cr	₹134 Cr	₹23 Cr
₹14 L	₹10 L	₹4 L
₹101 Cr	₹134 Cr	₹24 Cr
₹90 Cr	₹125 Cr	₹19 Cr
₹12 Cr	₹10 Cr	₹4 Cr
₹1 Cr	₹1 Cr	₹27 L
₹10 Cr	₹8 Cr	₹4 Cr
₹9 Cr	₹8 Cr	₹3 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025
—	—
₹42 Cr	₹10 Cr
₹2 Cr	₹4 Cr
₹289 Cr	₹22 Cr
₹289 Cr	₹22 Cr
₹334 Cr	₹36 Cr
₹19 Cr	₹46 L
₹86 L	₹12 L
₹65 L	₹0
₹20 Cr	₹57 L
—	—
₹124 Cr	₹11 Cr
₹11 Cr	₹3 Cr
₹30 Cr	₹13 Cr
₹165 Cr	₹27 Cr
₹519 Cr	₹63 Cr
₹49 Cr	₹13 Cr
—	—
₹70 Cr	₹16 Cr
₹5 Cr	₹4 Cr
₹64 Cr	₹11 Cr
₹203 Cr	₹0
₹203 Cr	₹0
₹4 Cr	₹4 Cr
₹3 Cr	₹2 Cr
₹276 Cr	₹18 Cr
—	—
₹68 Cr	₹15 Cr
₹157 Cr	₹28 Cr
₹70 L	₹2 Cr
₹18 Cr	₹1 Cr
₹243 Cr	₹46 Cr
₹78 Cr	₹19 Cr
₹519 Cr	₹63 Cr
₹79	₹33
₹79	₹33

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025
₹18 Cr	₹12 Cr
₹3 Cr	₹80 L
-₹37 Cr	-₹25 Cr
-₹17 Cr	-₹12 Cr
-₹18 Cr	-₹13 Cr
-₹2 Cr	-₹8 Cr
₹3 Cr	₹3 Cr
-₹17 Cr	-₹17 Cr
-₹11 Cr	₹6 Cr
-₹28 Cr	-₹11 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Astal Laboratories Share Price

54.27+3.02 (+5.89%)

-44.40% past 1 Year

Shareholding summary

Promoters

4.59%

FII

DII

Others

95.41%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
4.59%	4.53%	4.70%	18.19%	18.19%	18.19%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
95.41%	95.47%	95.30%	81.81%	81.81%	81.81%

Bulk & block deals

Name

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange

Insider trading & SAST

Client name

Aceso Research Labs Llp

Sesha Sai Nikhil Chintalapati

Sesha Sai Nikhil Chintalapati & Others

Kommera Harish

Suryanarayana Raju Rudraraju & Others

Vupparapalli Chandra Sekhar Reddy & Vupparapalli Pavani

Doradla Radha Krishna Huf & Others

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
11 Sep 2026	Promoter	Acquisition	0.060208	4.59	20 L	₹78.68	25.42 K	24 Aug 2026 - 08 Sep 2026	Market Purchase	20,11,012	Insider Trading	—	Equity
08 Apr 2026	Promoter	Acquisition	0.05	4.69	0	—	21.01 K	11 Mar 2026 - 19 Mar 2026	Market	19,80,291	SAST	29(2)	—
19 Mar 2026	Promoter	Acquisition	0.213701	4.69	15.68 L	₹74.63	21.01 K	11 Mar 2026 - 19 Mar 2026	Market Purchase	19,80,291	Insider Trading	—	Equity Shares
12 Feb 2026	Other	Acquisition	11.53	11.82	0	—	48.67 L	14 Jan 2026	Pref. Allotment	49,87,785	SAST	29(1)	—
11 Feb 2026	Other	Acquisition	11.53	11.82	0	—	48.67 L	14 Jan 2026	Pref. Allotment	49,87,785	SAST	29(1)	—
11 Feb 2026	Other	Acquisition	6.39	6.67	0	—	26.98 L	14 Jan 2026	Pref. Allotment	28,15,140	SAST	29(1)	—
11 Feb 2026	Other	Acquisition	7	7	0	—	29.57 L	14 Jan 2026	Pref. Allotment	29,56,666	SAST	29(1)	—
11 Feb 2026	Other	Acquisition	4.15	4.86	0	—	17.50 L	14 Jan 2026	Pref. Allotment	20,50,000	SAST	29(2)	—
11 Feb 2026	Other	Acquisition	2.55	4.53	0	—	10.75 L	14 Jan 2026	Pref. Allotment	19,10,370	SAST	29(2)	—

Astal Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Astal Laboratories Share Price

Astal Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Astal Laboratories Share Price

Astal Laboratories Share Price

Oscillators

Moving averages

Astal Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Astal Laboratories Share Price

Corporate Actions

Company details

Astal Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Astal Laboratories Share Price

News

Astal Laboratories reports Profit after tax of 1.09 Crores, in the March 2026 quarter

Astal Laboratories informs about disclosure

Astal Laboratories reports Profit after tax of 2.36 Crores, in the December 2025 quarter

Astal Laboratories informs about disclosure

Astal Laboratories informs about disclosure

Astal Laboratories informs about disclosure

Astal Laboratories signs LoI with Immuna Therapeutics GmbH

Astal Laboratories reports Profit after tax of 2.58 Crores, in the September 2025 quarter

Astal Laboratories submits intimation of corrigendum to EGM notice

Astal Laboratories - Quaterly Results

Astal Laboratories - Quaterly Results

Astal Laboratories reports Profit after tax of 2.09 Crores, in the June 2025 quarter

Astal Laboratories reports Profit after tax of 2.74 Crores, in the March 2025 quarter

Astal Laboratories - Quaterly Results

Astal Laboratories - Quaterly Results

Astal Laboratories - Quaterly Results

Astal Laboratories - Quaterly Results

Astal Laboratories - Quaterly Results

Astal Laboratories reports Profit after tax of 2.49 Crores, in the December 2024 quarter

Astal Laboratories informs about disclosures

Astal Laboratories Ltd Share Price Today

Astal Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator